STRS Ohio’s Fortress Biotech FBIO Stock Holding History

STRS Ohio’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,440	Closed	-$70K	–	2118
2022 Q1	$70K	Hold	3,440	–	–	﹤0.01%	1903
2021 Q4	$129K	Buy	3,440 +2,153	+167%	+$96K	﹤0.01%	1841
2021 Q3	$62K	Buy	+1,287	New	+$62.8K	﹤0.01%	2034
2019 Q2	–	Sell	-18,500	Closed	-$476K	–	2137
2019 Q1	$493K	Sell	18,500 -7,153	-28%	-$188K	﹤0.01%	1288
2018 Q4	$330K	Buy	25,653 +9,953	+63%	+$166K	﹤0.01%	1465
2018 Q3	$376K	Buy	15,700 +2,227	+17%	+$71.3K	﹤0.01%	1510
2018 Q2	$602K	Buy	13,473 +5,060	+60%	+$285K	﹤0.01%	1279
2018 Q1	$574K	Sell	8,413 -2,167	-20%	-$137K	﹤0.01%	1259
2017 Q4	$633K	Buy	10,580 +1,320	+14%	+$77.7K	﹤0.01%	1222
2017 Q3	$613K	Buy	9,260 +6,953	+301%	+$469K	﹤0.01%	1281
2017 Q2	$164K	Buy	+2,307	New	+$136K	﹤0.01%	1551

Other funds holding FBIO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

STRS Ohio's FBIO Position: Q2 2022 in Review

STRS Ohio sold out of Fortress Biotech (FBIO) in Q2 2022, closing a stake of 3,440 shares — an estimated $70K sold.

STRS Ohio first reported a position in FBIO in Q2 2017 and held it in 11 quarters. The position peaked at $633K in Q4 2017. 66 funds tracked by Wall St. Rank hold FBIO as of Q2 2022.

STRS Ohio reported no remaining Fortress Biotech position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 3,440 Fortress Biotech shares in Q2 2022, an estimated $70K.
STRS Ohio first reported a position in Fortress Biotech in Q2 2017 and held it in 11 quarters.
STRS Ohio's Fortress Biotech position peaked at $633K in Q4 2017.
66 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.